Related Experiment Video
Updated: May 10, 2026
11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Mucin-like peptides from Echinococcus granulosus induce antitumor activity
Verónica Noya1, Sylvie Bay, María Florencia Festari
1Department of Immunobiology, School of Medicine, UdelaR, 11800 Montevideo, Uruguay.
International Journal of Oncology
|July 3, 2013
Summary
Parasite-derived mucin peptides from Echinococcus granulosus (Egmuc) activate natural killer (NK) cells and enhance dendritic cell maturation, showing potential for cancer vaccine development.
Area of Science:
- Immunology
- Parasitology
- Cancer Research
Background:
- Certain parasites exhibit antitumor properties.
- Helminth-derived molecules are being explored for therapeutic applications.
Purpose of the Study:
- To evaluate mucin peptides from Echinococcus granulosus (Egmuc) as potential inducers of antitumor activity.
- To investigate the immunomodulatory effects of Egmuc peptides on immune cells relevant to cancer immunity.
Main Methods:
- Immunization of mice with Egmuc peptides.
- Assessment of NK cell activation and splenocyte cytotoxic activity.
- In vitro analysis of dendritic cell maturation and cytokine production (IL-12p40p70, IL-6) upon Egmuc treatment.
- Evaluation of NK cell activation marker (CD69) expression on Egmuc-treated dendritic cells.
Main Results:
- Egmuc peptides increased activated NK cells in mouse spleens.
- Splenocytes from immunized mice showed enhanced tumor cell killing capacity.
- Egmuc peptides promoted LPS-induced dendritic cell maturation in vitro, increasing IL-12p40p70 and IL-6 production.
- Egmuc-treated dendritic cells enhanced NK cell activation, indicated by increased CD69 expression.
Conclusions:
- Egmuc peptides possess immunomodulatory properties that enhance anti-tumor immune responses.
- These findings support the potential of using parasite-derived molecules like Egmuc in the development of novel cancer vaccines.
Related Concept Videos
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...